Literature DB >> 29567651

Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome.

T Zhang1, Y Duan2,3, J Ye4, W Xu4, N Shu5, C Wang5, K Li6,7, Y Liu8,3.   

Abstract

BACKGROUND AND
PURPOSE: Anti-N-methyl-D-aspertate receptor encephalitis is an autoimmune-mediated disease without specific brain MRI features. Our aim was to investigate the brain MR imaging characteristics of anti-N-methyl-D-aspartate receptor encephalitis and their associations with clinical outcome at a 2-year follow-up.
MATERIALS AND METHODS: We enrolled 53 patients with anti-N-methyl-D-aspartate receptor encephalitis and performed 2-year follow-up. Brain MRIs were acquired for all patients at the onset phase. The brain MR imaging manifestations were classified into 4 types: type 1: normal MR imaging findings; type 2: only hippocampal lesions; type 3: lesions not involving the hippocampus; and type 4: lesions in both the hippocampus and other brain areas. The modified Rankin Scale score at 2-year follow-up was assessed, and the association between the mRS and onset brain MR imaging characteristics was evaluated.
RESULTS: Twenty-eight (28/53, 53%) patients had normal MR imaging findings (type 1), and the others (25/53, 47%) had abnormal MRI findings: type 2: 7 patients (13%); type 3: seven patients (13%); and type 4: eleven patients (21%). Normal brain MRI findings were more common in female patients (P = .02). Psychiatric and behavioral abnormalities were more common in adults (P = .015), and autonomic symptoms (P = .025) were more common in pediatric patients. The presence of hippocampal lesions (P = .008, OR = 9.584; 95% CI, 1.803-50.931) and relapse (P = .043, OR = 0.111; 95% CI, 0.013-0.930) was associated with poor outcome.
CONCLUSIONS: Normal brain MRI findings were observed in half of the patients. Lesions in the hippocampus were the most common MR imaging abnormal finding. The presence of hippocampal lesions is the main MR imaging predictor for poor prognosis in patients with anti-N-methyl-D-aspartate receptor encephalitis.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 29567651     DOI: 10.3174/ajnr.A5593

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Altered cerebral blood flow in patients with anti-NMDAR encephalitis.

Authors:  Ailiang Miao; Qianqian Liu; Zonghong Li; Wen Liu; Lingling Wang; Jianqing Ge; Chuanyong Yu; Yingxin Wang; Shuyang Huang; Yuanwen Yu; Qi Shi; Jintao Sun; Xiaoshan Wang
Journal:  J Neurol       Date:  2020-03-04       Impact factor: 4.849

2.  Life After Tetra Hit: Anti-NMDAR Encephalitis After HSV Encephalitis in a NMOSD Coexistent with Sjögren's Syndrome.

Authors:  Cansu Ayvacioğlu Çağan; Rahşan Göçmen; Nazire Pınar Acar Özen; Aslı Tuncer
Journal:  Noro Psikiyatr Ars       Date:  2022-04-12       Impact factor: 1.066

Review 3.  Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society.

Authors:  Josefine Tratwal; Rossella Labella; Nathalie Bravenboer; Greet Kerckhofs; Eleni Douni; Erica L Scheller; Sammy Badr; Dimitrios C Karampinos; Sarah Beck-Cormier; Biagio Palmisano; Antonella Poloni; Maria J Moreno-Aliaga; Jackie Fretz; Matthew S Rodeheffer; Parastoo Boroumand; Clifford J Rosen; Mark C Horowitz; Bram C J van der Eerden; Annegreet G Veldhuis-Vlug; Olaia Naveiras
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-28       Impact factor: 5.555

4.  Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.

Authors:  Ran Zhou; Fei Jiang; Haobing Cai; Qiuming Zeng; Huan Yang
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

5.  Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients.

Authors:  Stefan Macher; Friedrich Zimprich; Desiree De Simoni; Romana Höftberger; Paulus S Rommer
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

6.  Longitudinal brain morphology in anti-NMDA receptor encephalitis: a case report with controls.

Authors:  Heikki Laurikainen; Iina Isotupa; Mikko Nyman; Tuula Ilonen; Teija Nummelin; Raimo K R Salokangas; Jarmo Hietala
Journal:  BMC Psychiatry       Date:  2019-05-10       Impact factor: 3.630

7.  Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Authors:  Laure Thouvenin; Timothée Olivier; Giuseppe Banna; Alfredo Addeo; Alex Friedlaender
Journal:  Ther Adv Drug Saf       Date:  2021-03-29

8.  Progressive cortical and sub-cortical alterations in patients with anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Jinping Xu; Yuanyuan Guo; Jiaying Li; Xinyi Lv; Juanjuan Zhang; Jinhuan Zhang; Qingmao Hu; Kai Wang; Yanghua Tian
Journal:  J Neurol       Date:  2021-07-23       Impact factor: 4.849

9.  Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder.

Authors:  Souvik Dubey; Ritwik Ghosh; Mahua Jana Dubey; Samya Sengupta; Julián Benito-León; Biman Kanti Ray
Journal:  J Neuroimmunol       Date:  2020-07-22       Impact factor: 3.478

10.  Solitary juxtacortical lesion associated with anti-N-methyl-D-aspartate receptor encephalitis: a case report.

Authors:  Rupan Gao; Xiang Zhang; Abhijeet Kumar Bhekharee; Yue Zhang
Journal:  BMC Neurol       Date:  2020-11-20       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.